Astellas Pharma Inc. — Investor Relations & Filings
Filings indexed
78
across all filing types
Latest filing
2022-08-05
Interim / Quarterly Rep…
Country
JP
Japan
Listing
T
4503
Astellas Pharma Inc. is a global pharmaceutical company dedicated to improving human health by turning innovative science into value for patients. The company's core activities encompass the research, development, manufacture, and commercialization of novel pharmaceutical products. Astellas focuses on pioneering transformative therapies in disease areas with high unmet medical needs, including oncology, ophthalmology, urology, immunology, and women's health. Through its patient-centric approach and robust research and development programs, the company aims to deliver innovative healthcare solutions worldwide.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 四半期報告書－第18期第1四半期(令和4年4月1日－令和4年6月30日) | 2022-08-05 | Japanese | |
| 確認書 | 2022-06-20 | Japanese | |
| 内部統制報告書－第17期(令和3年4月1日－令和4年3月31日) | 2022-06-20 | Japanese | |
| 有価証券報告書－第17期(令和3年4月1日－令和4年3月31日) | 2022-06-20 | Japanese | |
| 四半期報告書－第17期第3四半期(令和3年10月1日－令和3年12月31日) | 2022-02-07 | Japanese | |
| 四半期報告書－第17期第2四半期(令和3年7月1日－令和3年9月30日) | 2021-11-05 | Japanese |
Browse filings by year
12 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
5 filings
| |||||
| 7595393 | 四半期報告書－第18期第1四半期(令和4年4月1日－令和4年6月30日) | 2022-08-05 | Japanese | ||
| 7604917 | 確認書 | 2022-06-20 | Japanese | ||
| 7604914 | 内部統制報告書－第17期(令和3年4月1日－令和4年3月31日) | 2022-06-20 | Japanese | ||
| 7604918 | 有価証券報告書－第17期(令和3年4月1日－令和4年3月31日) | 2022-06-20 | Japanese | ||
| 7618419 | 四半期報告書－第17期第3四半期(令和3年10月1日－令和3年12月31日) | 2022-02-07 | Japanese | ||
|
2021
6 filings
| |||||
| 7624701 | 四半期報告書－第17期第2四半期(令和3年7月1日－令和3年9月30日) | 2021-11-05 | Japanese | ||
| 7662028 | 四半期報告書－第17期第1四半期(令和3年4月1日－令和3年6月30日) | 2021-08-06 | Japanese | ||
| 7670314 | 内部統制報告書－第16期(令和2年4月1日－令和3年3月31日) | 2021-06-18 | Japanese | ||
| 7670313 | 確認書 | 2021-06-18 | Japanese | ||
| 7670317 | 有価証券報告書－第16期(令和2年4月1日－令和3年3月31日) | 2021-06-18 | Japanese | ||
| 7677541 | 四半期報告書－第16期第3四半期(令和2年10月1日－令和2年12月31日) | 2021-02-05 | Japanese | ||
|
2020
4 filings
| |||||
| 7682391 | 四半期報告書－第16期第2四半期(令和2年7月1日－令和2年9月30日) | 2020-11-06 | Japanese | ||
| 7686432 | 四半期報告書－第16期第1四半期(令和2年4月1日－令和2年6月30日) | 2020-08-07 | Japanese | ||
| 7690081 | 有価証券報告書－第15期(平成31年4月1日－令和2年3月31日) | 2020-06-18 | Japanese | ||
| 7694336 | 四半期報告書－第15期第3四半期(令和1年10月1日－令和1年12月31日) | 2020-02-07 | Japanese | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Astellas Pharma Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/11357/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=11357 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=11357 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=11357 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 11357}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Astellas Pharma Inc. (id: 11357)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.